| Literature DB >> 22336384 |
Gonzalo García1, Isabel Serrano, Patricia Sánchez-Alonso, Manuel Rodríguez-Puyol, Ramón Alajarín, Mercedes Griera, Juan J Vaquero, Diego Rodríguez-Puyol, Julio Alvarez-Builla, María L Díez-Marqués.
Abstract
We report new examples of a series of losartan-hydrocaffeic hybrids that bear novel ester, amide and amine linkers. These compounds were made by linking hydrocaffeic acid to the side chain of losartan at the C-5 position of the imidazole ring through different strategies. Experiments performed in cultured cells demonstrate that these new hybrids retain the ability to block the angiotensin II effect and have increased antioxidant ability. Most of them reduced arterial pressure in rats better or as much as losartan. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22336384 DOI: 10.1016/j.ejmech.2012.01.043
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514